Join to view full profile
2940 S MeridianSte 100Puyallup, WA 98373
Dr. Blau is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1997
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1990 - 1993
OtherClass of 1987
Certifications & Licensure
OH State Medical License 1992 - 2028
WA State Medical License 1999 - 2028
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2013, 2015, 2017
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2013, 2015, 2017
Clinical Trials
- ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study Start of enrollment: 2023 May 19
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- A real-world study evaluating drug tolerability and health care resource use with acalabrutinib vs ibrutinib in patients with relapsed/refractory chronic lymphocytic l...George Dranitsaris, Aaron Peevyhouse, Heather Neuhalfen, Lee Ann Dietz, Chanh Huynh
Journal of Medical Economics. 2026-12-01 - 1 citationsOptimizing Oncology Care Through Collaborative Teams.Sibel Blau, Valerie Csik, Eric Tetzlaff, Todd Pickard, Jennifer Marks
JCO Oncology Practice. 2026-08-14 - Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLL.Mayur S Narkhede, Sibel Blau, Aaron Peevyhouse, Heather Neuhalfen, Lee Ann Dietz
Leukemia & Lymphoma. 2026-08-01
Press Mentions
Cancer Practices Still Concerned About CMS Enhancing Oncology Model More Than 2 Years inSeptember 12th, 2025- Jvion Drives Adoption of Prescriptive Intelligence and Clinical AI with New Peer-Reviewed Results, Platform Integrations and SDOH SolutionsSeptember 10th, 2021
- Quality Cancer Care Alliance and ConcertAI Partner on Novel Digital Clinical Trial Solutions, Accelerating Patient Access to Clinical TrialsAugust 31st, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: